Literature DB >> 15361867

GA binding protein regulates interleukin 7 receptor alpha-chain gene expression in T cells.

Hai-Hui Xue1, Julie Bollenbacher, Valentina Rovella, Radhika Tripuraneni, Yu-Bin Du, Cheng-Yu Liu, Ann Williams, J Philip McCoy, Warren J Leonard.   

Abstract

The interleukin 7 receptor alpha-chain (IL-7Ralpha) is essential for T cell development in both humans and mice and for B cell development in mice. Whereas the transcription factor PU.1 regulates IL-7Ralpha expression in mouse pro-B cells via a GGAA motif, we demonstrate here that GA binding protein (GABP) bound to this site and was essential in the regulation of IL-7Ralpha expression in T cells, where PU.1 is not expressed. Moreover, IL-7Ralpha expression was diminished substantially in thymocytes but was normal on B220(+) fetal liver cells from mouse embryos with diminished expression of GABPalpha. Thus, GABP is essential for the regulation of IL-7Ralpha expression in T cells, and the differential regulation of IL-7Ralpha in distinct lymphoid lineages is achieved at least in part by differential recruitment of factors to the same GGAA motif.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361867     DOI: 10.1038/ni1117

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  61 in total

1.  GABP controls a critical transcription regulatory module that is essential for maintenance and differentiation of hematopoietic stem/progenitor cells.

Authors:  Shuyang Yu; Kairong Cui; Raja Jothi; Dong-Mei Zhao; Xuefang Jing; Keji Zhao; Hai-Hui Xue
Journal:  Blood       Date:  2010-12-07       Impact factor: 22.113

Review 2.  Forging T-Lymphocyte Identity: Intersecting Networks of Transcriptional Control.

Authors:  Ellen V Rothenberg; Jonas Ungerbäck; Ameya Champhekar
Journal:  Adv Immunol       Date:  2015-10-26       Impact factor: 3.543

3.  Maturation stage-specific regulation of megakaryopoiesis by pointed-domain Ets proteins.

Authors:  Liyan Pang; Hai-Hui Xue; Gabor Szalai; Xun Wang; Yuhuan Wang; Dennis K Watson; Warren J Leonard; Gerd A Blobel; Mortimer Poncz
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

Review 4.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

Review 5.  Launching the T-cell-lineage developmental programme.

Authors:  Ellen V Rothenberg; Jonathan E Moore; Mary A Yui
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

6.  GABPbeta2 is dispensible for normal lymphocyte development but moderately affects B cell responses.

Authors:  Xuefang Jing; Dong-Mei Zhao; Thomas J Waldschmidt; Hai-Hui Xue
Journal:  J Biol Chem       Date:  2008-07-15       Impact factor: 5.157

7.  Differential response of regulatory and conventional CD4⁺ lymphocytes to CD3 engagement: clues to a possible mechanism of anti-CD3 action?

Authors:  Li Li; Junko Nishio; André van Maurik; Diane Mathis; Christophe Benoist
Journal:  J Immunol       Date:  2013-08-28       Impact factor: 5.422

8.  Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice.

Authors:  Nicolas Leuenberger; Sylvain Pradervand; Walter Wahli
Journal:  J Clin Invest       Date:  2009-10       Impact factor: 14.808

9.  GABP transcription factor (nuclear respiratory factor 2) is required for mitochondrial biogenesis.

Authors:  Zhong-Fa Yang; Karen Drumea; Stephanie Mott; Junling Wang; Alan G Rosmarin
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

10.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.

Authors:  D R Booth; A T Arthur; S M Teutsch; C Bye; J Rubio; P J Armati; J D Pollard; R N S Heard; G J Stewart
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.